{
    "2019-06-17": [
        [
            {
                "time": "",
                "original_text": "“青蒿素抗药性”研究获突破刺激医药板块拉升，券商建议配置三类股",
                "features": {
                    "keywords": [
                        "青蒿素",
                        "抗药性",
                        "研究突破",
                        "医药板块",
                        "券商建议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-06-20",
                "original_text": "[快讯]爱尔眼科171万股限售股6月20日解禁 解禁",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "限售股",
                        "解禁"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-06-20",
                "original_text": "爱尔眼科：解锁实际可上市流通的限售股1339.69万股，占公司总股本比例0.43% 解禁",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "限售股",
                        "流通",
                        "解禁"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "业内首只医疗ETF正式上市 填补市场空白",
                "features": {
                    "keywords": [
                        "医疗ETF",
                        "正式上市",
                        "填补空白"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物改革短期镇痛下寻找结构调整中的机遇，维持“增持”评级",
                "features": {
                    "keywords": [
                        "医药生物",
                        "改革",
                        "结构调整",
                        "机遇",
                        "增持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}